4502:TYO
Takeda Pharmaceutical Co Ltd
¥5,843.00
arrow_upward
+0.46%(+27.00) 1D
Okt 9, 3:30:00 PM GMT+9 · JPY
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 4502...
Buksan
¥5,820
Mataas
¥5,853
Mababa
¥5,783
Mkt. cap
9.36T
Avg. na dami
4.13M
Dami
3.66M
Dividend
3.42%
Bawat tatlong buwang dividend
¥50
Petsa ng ex-dividend
Set 29, 2026
Mataas nang 52-wk
¥6,033
Mababa nang 52-wk
¥4,102
EPS
-¥103
Mga natitirang share
784.48M
Bilang ng mga empleyado
47K
Buksan
¥5,820
Mataas
¥5,853
Mababa
¥5,783
Mkt. cap
9.36T
Avg. na dami
4.13M
Dami
3.66M
Dividend
3.42%
Bawat tatlong buwang dividend
¥50
Petsa ng ex-dividend
Set 29, 2026
Mataas nang 52-wk
¥6,033
Mababa nang 52-wk
¥4,102
EPS
-¥103
Mga natitirang share
784.48M
Bilang ng mga empleyado
47K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TipRanks
·
4 oras ang nakalipas
Takeda Advances Pediatric Vedolizumab Trial, Strengthening Its IBD Growth Story
AD HOC NEWS
·
6 oras ang nakalipas
Takeda Pharmaceutical stock trades at EUR 16.55 with a P/ E of 52.1
AD HOC NEWS
·
14 oras ang nakalipas
Takeda Pharmaceutical stock pre-market at EUR 16.55: unchanged
TipRanks
·
1 araw ang nakalipas
Takeda’s CDPATH™ Study Signals Growing Focus on Data‑Driven Crohn’s Care
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Tungkol sa Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Mga Empleyado47K
ItinatagHun 12, 1781
Headquarters-
Sektor-
Websitetakeda.com